Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Tenon Medical (TNONW) Research & Development (2021 - 2025)

Historic Research & Development for Tenon Medical (TNONW) over the last 5 years, with Q3 2025 value amounting to $428000.0.

  • Tenon Medical's Research & Development fell 3485.54% to $428000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.2 million, marking a year-over-year decrease of 1959.63%. This contributed to the annual value of $2.6 million for FY2024, which is 1770.47% down from last year.
  • As of Q3 2025, Tenon Medical's Research & Development stood at $428000.0, which was down 3485.54% from $503000.0 recorded in Q2 2025.
  • In the past 5 years, Tenon Medical's Research & Development ranged from a high of $901000.0 in Q2 2023 and a low of $87000.0 during Q1 2021
  • Over the past 5 years, Tenon Medical's median Research & Development value was $669000.0 (recorded in 2024), while the average stood at $628105.3.
  • As far as peak fluctuations go, Tenon Medical's Research & Development soared by 54597.7% in 2022, and later tumbled by 3485.54% in 2025.
  • Tenon Medical's Research & Development (Quarter) stood at $793000.0 in 2021, then rose by 2.4% to $812000.0 in 2022, then dropped by 14.9% to $691000.0 in 2023, then dropped by 17.66% to $569000.0 in 2024, then decreased by 24.78% to $428000.0 in 2025.
  • Its Research & Development stands at $428000.0 for Q3 2025, versus $503000.0 for Q2 2025 and $691000.0 for Q1 2025.